Literature DB >> 21432612

Developmental comorbidity in attention-deficit/hyperactivity disorder.

Regina Taurines1, Jochen Schmitt, Tobias Renner, Alex Curtis Conner, Andreas Warnke, Marcel Romanos.   

Abstract

With the present review, we intend to highlight the importance of considering the age- and development-dependent occurrence of comorbidity in ADHD and to outline distinct trajectories of symptom progression with possible impact on course and outcome of ADHD. The review will focus on introducing the concepts of "developmental epidemiology" and "developmental comorbidity". Psychiatric and non-psychiatric age-dependent comorbidity can be seen in the majority of children, adolescents and adults with ADHD, resulting in a severe impairment of everyday life with considerable functional and psychosocial problems. Concerning the temporal order of occurrence, psychiatric conditions may be present before the appearance of first definite ADHD symptoms ("pre-comorbidity", such as temperament factors, sleep disturbance, autism spectrum disorders and atopic eczema). They may coincide with the time when ADHD symptoms reach a clinically significant level ("simultaneous comorbidity": enuresis, encopresis, developmental dyslexia). The majority of comorbidity, however, appears after the onset of ADHD in the course of disease ("post-comorbidity": tic disorder, depression and suicidality, anxiety disorders, obsessive compulsive disorder, bipolar disorder, conduct and substance use disorders, obesity and personality disorders). The aetio-pathophysiology of ADHD and its comorbid disorders and also the nature of comorbidity itself being highly heterogeneous, we additionally discuss possible models of comorbidity. In the future, longitudinal data on distinct patterns of symptom and comorbidity progression would help to refine disease classification systems, strengthen the power of future genetic studies and finally allow for more specific treatment strategies.

Entities:  

Mesh:

Year:  2010        PMID: 21432612     DOI: 10.1007/s12402-010-0040-0

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  43 in total

1.  Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder.

Authors:  Regina Taurines; Monica Segura; Martin Schecklmann; Laura Albantakis; Edna Grünblatt; Susanne Walitza; Thomas Jans; Benjamin Lyttwin; Michael Haberhausen; Frank M Theisen; Berthold Martin; Wolfgang Briegel; Johannes Thome; Christina Schwenck; Marcel Romanos; Manfred Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2014-02-06       Impact factor: 3.575

2.  Association of attention-deficit/hyperactivity disorder with gambling disorder.

Authors:  Wolfgang Retz; Jutta Ringling; Petra Retz-Junginger; Monika Vogelgesang; Michael Rösler
Journal:  J Neural Transm (Vienna)       Date:  2016-06-21       Impact factor: 3.575

3.  Mental health and sleep habits/problems in children aged 3-4 years: a population study.

Authors:  Fumie Horiuchi; Kentaro Kawabe; Yasunori Oka; Kiwamu Nakachi; Rie Hosokawa; Shu-Ichi Ueno
Journal:  Biopsychosoc Med       Date:  2021-05-20

4.  Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.

Authors:  Melissa Voigt Hansen; Lise Darling; Helle Holst
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

5.  Anxiety Disorders Comorbidity in Children and Adolescents with Attention Deficit Hyperactivity Disorder.

Authors:  Yusuf Yasin Gümüş; Nursu Çakin Memik; Belma Ağaoğlu
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

6.  Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial.

Authors:  Ahmad Ghanizadeh; Rezvan Haghighat
Journal:  Pediatr Nephrol       Date:  2012-06-15       Impact factor: 3.714

Review 7.  Attention-deficit/hyperactivity disorder and adverse health outcomes.

Authors:  Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2012-12-07

8.  ADHD and depressive symptoms in adolescents: the role of community violence exposure.

Authors:  Andrew Stickley; Roman Koposov; Ai Koyanagi; Yosuke Inoue; Vladislav Ruchkin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-01-31       Impact factor: 4.328

9.  Latent Class Analysis of ADHD Neurodevelopmental and Mental Health Comorbidities.

Authors:  Benjamin Zablotsky; Matthew D Bramlett; Susanna N Visser; Melissa L Danielson; Stephen J Blumberg
Journal:  J Dev Behav Pediatr       Date:  2018-01       Impact factor: 2.225

10.  Mental health comorbidity in patients with atopic dermatitis.

Authors:  Pouya Yaghmaie; Caroline W Koudelka; Eric L Simpson
Journal:  J Allergy Clin Immunol       Date:  2012-12-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.